Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 28, Issue 4, 2015, Pages 299-307

  Birkun, Alexei A ^a   Kubyshkin, Anatoly V ^a   Novikov, Nikolai Y ^a   Krivorutchenko, Yuri L ^a   Fedosov, Michael I ^a   Postnikova, Olga N ^a   Snitser, Anatoly A ^a  

^a V I VERNADSKY CRIMEAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

amikacin; antimicrobial; delivery; exogenous surfactant; pneumonia; vehicle

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; LUNG SURFACTANT; ANTIINFECTIVE AGENT; DRUG CARRIER; DRUG COMBINATION;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; EMULSION; EXPERIMENTAL INFECTION; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RAT; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; LUNG; MALE; MEDICINAL CHEMISTRY; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; WISTAR RAT;

ADMINISTRATION, INHALATION; AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMBINATIONS; LUNG; MALE; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY SURFACTANTS; RATS, WISTAR;

EID: 84938339508     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2014.1161     Document Type: Article

References (10)

1. Baldwin DR, Honeybourne D, and Wise R: Pulmonary disposition of antimicrobial agents: In vivo observations and clinical relevance. Antimicrob Agents Chemother. 1992;36:1176-1180.
2. van Daal GJ, So KL, Gommers D, Eijking EP, Fiévez RB, Sprenger MJ, van Dam DW, and Lachmann B: Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth Analg. 1991;72:589-595.
3. Kharasch VS, Sweeney TD, Fredberg J, Lehr J, Damokosh AI, Avery ME, and Brain JD: Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs. Am Rev Respir Dis. 1991;144:909-913.
4. van't Veen A, Mouton JW, Gommers D, and Lachmann B: Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae. Br J Pharmacol. 1996;119:1145-1148.
5. Stichtenoth G, Linderholm B, Björkman MH, Walter G, Curstedt T, and Herting E: Prophylactic intratracheal polymyxin B/surfactant prevents bacterial growth in neonatal Escherichia coli pneumonia of rabbits. Pediatr Res. 2010;67:369-374.
6. Birkun A: Exogenous pulmonary surfactant as a vehicle for antimicrobials: Assessment of surfactant-Antibacterial interactions in vitro. Scientifica [Online]. 2014; 2014: 930318.
7. Pattle RE, Kratzing CC, Parkinson CE, Graves L, Robertson RD, Robards GJ, Currie JO, Parsons JH, and Sutherland PD: Maturity of fetal lungs tested by production of stable microbubbles in amniotic fluid. Br J Obstet Gynaecol. 1979;86:615-622.
8. Sun Y, Wang YQ, Yang R, Zhu JJ, Le YY, Zhong JG, and Lu J: Exogenous porcine surfactants increase the infiltration of leukocytes in the lung of rats. Pulm Pharmacol Ther. 2009;22:253-259.
9. Khan AJ, Evans HE, Glass L, Khan P, Chang CT, and Nair SR: Abnormal neutrophil chemotaxis and random migration induced by aminoglycoside antibiotics. J Lab Clin Med. 1979;93:295-300.
10. van 't Veen A, Gommers D, Mouton JW, Kluytmans JA, Krijt EJ, and Lachmann B: Exogenous pulmonary surfactant as a drug delivering agent: Influence of antibiotics on surfactant activity. Br J Pharmacol. 1996;118:593-598.